Results 251 to 260 of about 69,249 (312)

Neurostimulation for Generalized Epilepsy: Should Therapy be Syndrome-specific? [PDF]

Neurosurg Clin N Am
Warren AEL, Tobochnik S, Chua MMJ, Singh H, Stamm MA, Rolston JD.   +5 more
europepmc   +1 more source

Second-Line Medications for Women Aged 10 to 50 Years With Idiopathic Generalized Epilepsy.

JAMA Netw Open
Cerulli Irelli E, Cocchi E, Gesche J, Peña-Ceballos J, Caraballo RH, Lattanzi S, Strigaro G, Morano A, Moloney PB, Ferlazzo E, Pascarella A, Mazzeo A, D'Aniello A, Pizzanelli C, Milano C, Giuliano L, Viola V, Mostacci B, Fortunato F, Pulitano P, Burani M, Meletti S, Pignatta P, Perulli M, Battaglia D, Rosati E, Delanty N, Di Gennaro G, Gambardella A, Labate A, Operto FF, Giallonardo AT, Beier CP, Di Bonaventura C, Women with Epilepsy Treatment Options and Research (WETOR) study group.   +34 more
europepmc   +1 more source

Auditory evoked responses (ABR-MLR) in the primary generalized epilepsy

, 1988
Frenguelli,A, Molini, E, Fausti,R, Rossi, A, Picchiarelli, A, Capocchi,G, Zampolini, M, OTTAVIANI, FABRIZIO   +7 more
core  

Some of the next articles are maybe not open access.

Related searches:

Cenobamate in Generalized Epilepsy and Combined Generalized and Focal Epilepsy

Neurology Clinical Practice, 2023
Cenobamate (CNB) is a United States Food and Drug Administration-approved antiseizure medication (ASM) for focal-onset seizures; however, its potential clinical effectiveness as a broad-spectrum ASM is not established. CNB has a proposed dual mechanism of action with preferential blockade of persistent sodium currents and positive allosteric modulation
Shruti Agashe, Gregory Worrell, Jeffrey Britton, Katherine Noe, Anthony Ritaccio, Elaine C. Wirrell, Katherine C. Nickels, Gregory D. Cascino, David Burkholder   +8 more
openaire   +2 more sources

Genetic Generalized Epilepsies

Journal of Clinical Neurophysiology, 2012
In the International League Against Epilepsy's most recent revision of classification and terminology, the term idiopathic epilepsy, previously used to describe those epilepsies whose cause was unknown, but presumed genetic, has been removed. It has been replaced by the term genetic epilepsy, only to be used to describe epilepsy in which the etiology ...
William B, Gallentine, Mohamad A, Mikati
openaire   +2 more sources

Idiopathic generalized epilepsy

Current Treatment Options in Neurology, 2004
Successful treatment of idiopathic generalized epilepsy begins with accurate seizure classification. Seizure types, such as absence, myoclonic, and primary generalized tonic-clonic seizures (PGTCS), often can be classified based on a detailed history and inter-ictal electroencephalogram (EEG).
Joseph E., Sullivan, Dennis J., Dlugos
openaire   +2 more sources

Photosensitivity in generalized epilepsies

Epilepsy & Behavior, 2017
Photosensitivity, which is the hallmark of photosensitive epilepsy (PSE), is described as an abnormal EEG response to visual stimuli known as a photoparoxysmal response (PPR). The PPR is a well-recognized phenomenon, occurring in 2-14% of patients with epilepsy but its pathophysiology is not clearly understood.
Shervonne, Poleon, Jerzy P, Szaflarski
openaire   +2 more sources

Primary generalized epilepsies

Current Treatment Options in Neurology, 2000
For pure childhood absence epilepsy (CAE), ethosuximide (ESM) remains the drug of first choice. Although valproic acid (VPA) is of equal efficacy, it is more toxic, and is reserved for those patients with accompanying convulsions. Lamotrigine (LTG) is effective as both add-on and monotherapy for CAE.
, Murphy, , Delanty
openaire   +2 more sources